NEW YORK (GenomeWeb) – Circulogene announced today that it has signed a license agreement for its molecular cancer diagnostic technology with Turkish lab Circulogene Saglik, a subsidiary of GGT Global Genetik.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.